Complete report is spread across 487 pages and available @ http://www.reportsnreports.com/reports/279987-psoriasis-pipeline-review-h1-2014.html. Psoriasis - Pipeline Review, H1 2014 report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities.

1. Psoriasis - Pipeline Review, H1 2014
Psoriasis - Pipeline Review, H1 2014
Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an
email on sales@reportsandreports.com with Psoriasis - Pipeline Review in subject
line and your contact details.
Psoriasis Market Pipeline Review, H1 2014, provides an overview of the Psoriasis’s therapeutic
pipeline.
This report provides comprehensive information on the therapeutic development for Psoriasis,
complete with comparative analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest
updates, and featured news and press releases. It also reviews key players involved in the
therapeutic development for Psoriasis and special features on late-stage and discontinued
projects
The report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from proprietary
databases, Company/University websites, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third party sources. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set of information.
Additionally, processes including live news & deals tracking, browser based alert-box and
clinical trials registries tracking ensure that the most recent developments are captured on a real
time basis.
Complete report is spread across 487 pages and available @
http://www.reportsnreports.com/reports/279987-psoriasis-pipeline-review-h1-
2014.html.
The report enhances decision making capabilities and help to create effective counter strategies
to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and
MOAs to produce first-in-class and best-in-class products.
Scope
- The report provides a snapshot of the global therapeutic landscape of Psoriasis
- The report reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental
activities

2. Psoriasis - Pipeline Review, H1 2014
- The report reviews key players involved in the therapeutics development for Psoriasis and
enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Psoriasis products under development by companies and universities/research
institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-
registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Psoriasis pipeline on the basis of target, MoA, route of administration and
molecule type
- Latest news and deals relating related to pipeline products
Buy a copy of report @
http://www.reportsnreports.com/purchase.aspx?name=279987.
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate
effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-
strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for
Psoriasis
- Plan mergers and acquisitions effectively by identifying key players of the most promising
pipeline
- Devise corrective measures for pipeline projects by understanding Psoriasis pipeline depth and
focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners
with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
List of Tables
Number of Products under Development for Psoriasis, H1 2014 28
Number of Products under Development for Psoriasis - Comparative Analysis, H1 2014 29
Number of Products under Development by Companies, H1 2014 31
Number of Products under Development by Companies, H1 2014 (Contd..1) 32
Number of Products under Development by Companies, H1 2014 (Contd..2) 33
Number of Products under Development by Companies, H1 2014 (Contd..3) 34

3. Psoriasis - Pipeline Review, H1 2014
Number of Products under Development by Companies, H1 2014 (Contd..4) 35
Number of Products under Development by Companies, H1 2014 (Contd..5) 36
Number of Products under Development by Companies, H1 2014 (Contd..6) 37
Number of Products under Development by Companies, H1 2014 (Contd..7) 38
Number of Products under Investigation by Universities/Institutes, H1 2014 40 & More.
Inquire for Discount @
http://www.reportsnreports.com/contacts/discount.aspx?name=279987.
List of Figures
Number of Products under Development for Psoriasis, H1 2014 28
Number of Products under Development for Psoriasis - Comparative Analysis, H1 2014 29
Number of Products under Development by Companies, H1 2014 30
Number of Products under Investigation by Universities/Institutes, H1 2014 39
Comparative Analysis by Late Stage Development, H1 2014 41
Comparative Analysis by Clinical Stage Development, H1 2014 42
Comparative Analysis by Early Stage Products, H1 2014 43
Assessment by Monotherapy Products, H1 2014 166
Number of Products by Top 10 Target, H1 2014 168
Number of Products by Stage and Top 10 Target, H1 2014 169
Number of Products by Top 10 Mechanism of Action, H1 2014 176
Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 177
Number of Products by Top 10 Route of Administration, H1 2014 184
Number of Products by Stage and Top 10 Route of Administration, H1 2014 185
Number of Products by Top 10 Molecule Type, H1 2014 187
Number of Products by Stage and Top 10 Molecule Type, H1 2014 188
Inquiry Before Buying @
http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=279987
Explore Report on Pharmaceuticals Market.
Contact sales@reportsandreports.com / Call +1 888 391 5441 for further
information on “Psoriasis - Pipeline Review, H1 2014” report OR for any other
market research and intelligence needs you may have for your business.